SUMMARY The role of renal prostaglandin* and the adrenergie nervous system in the control of rcnin release was studied in conscious dogs with thoracic caval constriction. lndomethacin reduced plasma renin activity (PRA) in intact animals with thoracic caval constriction by 43% but failed to change PRA after surgical renal denervation and during chronic propranolol administration; adrenergie blockade reduced the initial control level of PRA before indomethacin from 15 to 4 ng angiotensin I/ml per hr. Renal hemodynamic function was markedly reduced by indomethacin both before and after adrenergie blockade. These observations indicate that prostaglandins are involved ha the control of renin release, but they appear to have a more important role in the control of renal arterior resistance. The adrenergic nervous system also plays a role in the hyperreninemia of caval constriction and, possibly, a greater role than the renal prostaglandins. In the first experimental design, surgical renal denervation and daily oral propran'olol administration in dogs with caval constriction reduced PRA to normal in two of seven dogs and a natriuresis occurred. In four of the five remaining animals, PRA fell, but not to normal, and renal sodium excretion failed to increase. In a second experimental design, the kidneys were denervated and propranolol was given before the dogs were subjected to caval constriction and propranolol was continued for 5 days; PRA increased markedly, sodium retention occurred, and ascites formed. Under these circumstances, compensatory mechanisms secondary to caval constriction led to increased PRA in spite of adrenergie blockade. Ore Res 49: 492-500, 1981
RENIN release mechanisms have been studied extensively in dogs with chronic thoracic caval constriction, a model for low output heart failure (Davis and Freeman, 1976) . The decrease in cardiac output and, occasionally, in arterial pressure appears to activate both the vascular receptor in the renal afferent arteriole and the macula densa to increase renin release. The renal nerves are also important in mediating the increased renin secretion of thoracic caval constriction, since chronic bilateral renal denervation reduced plasma renin activity (PRA) by 50% in chronic conscious animals (Witty et al, 1972) . However, after this 50% reduction, PRA remained elevated 8-fold, renal sodium retention was almost complete, and ascites formation continued unabated.
Recently, it has been proposed (Oates et al., 1979 ) that renin secretion is controlled by two major pathways which are mediated by (1) the renal prostaglandins and (2) the adrenergie nervous system. The present study was designed to examine the role of prostaglandins and of the adrenergie nervous system in the control of renin release in dogs with chronic thoracic caval constriction. The acute response of PRA to indomethacin was studied in conscious animals. Subsequently, adrenergie. ner-vous effects on the kidney were eliminated by bilateral renal denervation and propranolol administration, and the acute renin response to indomethacin was observed again. Arterial pressure, renal hemodynamic function, and electrolyte metabolism were also studied to help define the action of indomethacin on renin release.
In studies of the chronic response to propranolol in conscious dogs with renal denervation and caval constriction, PRA returned to normal in two of seven animals and fell substantially in others. Because of this striking response to adrenergic blockade, another series of dogs was studied in which renal denervation was performed first and then large doses of oral propranolol were given. After 3 days of propranolol, the thoracic inferior vena cava was constricted to determine whether prior blockade of the adrenergic nervous system would prevent a rise in PRA and prevent sodium retention with ascites.
Methods
Female mongrel dogs (18-25 kg) were anesthetized with sodium pentobarbital (30 mg/kg, iv) and catheters were inserted into the femoral vessels and exteriorized through an incision at the back of the neck. A perineotomy was also performed to facilitate bladder catheterization. The thoracic inferior vena cava was constricted under sterile conditions to produce chronic sodium retention and ascites formation. The dogs were trained to lie quietly on a concave padded table. All experiments were done on conscious resting animals. The animals were fed a daily diet containing 35 mEq sodium, and the 24-hour urinary excretion of sodium was determined.
When the kidneys were denervated, each kidney was exposed retroperitoneally via a flank incision and the renal nerves were removed surgically from the renal vessels which were then painted with a 5% phenol solution. In previous studies (Gotshall et al., 1973) , this procedure reduced kidney norepinephrine content to near zero.
When <#-propranolol was given, the oral dose of 25 mg/kg per day was divided into three treatments given at 8:00 a.m., 4:00 p.m., and 10:00 p.m. Blood samples were taken at 8:00 a.m. before the morning dose to determine the minimal level of serum propranolol. The average serum propranolol level at this time (before 8:00 a.m.) was 741 ± 283 ng/ml (n = 7), and at no time was the observed level of propranolol lower than the y8-blocking dose of 45 ng/ml observed for this drug (Pettinger and Keeton, 1975) .
For determination of PRA, blood samples were collected in chilled tubes containing 0.1 ml 10% EDTA. The radioimmunoassay technique of Sealey et al. (1974) was used to measure angiotensin I. Separate blood samples were collected with sodium heparin as the anticoagulant for determination of plasma electrolytes. Urinary prostaglandin E^ was measured according to the method of Dray et al. (1975) . Urine was acidified to pH 3,0, extracted twice with 3 volumes cyclohexane: ethylacetate 1:1, and chromatographed on silicic acid columns. Recoveries were calculated using [ 3 H]PGE 2 additions to the original sample. Antiserum to PGE2 was obtained from Institute Pasteur, Paris. All values were corrected for the measured recoveries.
Indomethacin was given intravenously as a 5 mg/ kg bolus. Indomethacin was prepared by dissolving the compound in 5 ml ethyl alcohol. The solution was then adjusted to pH 8.3 with phosphate buffer. In a control study (DeForrest et al., 1980) with the present experimental design, indomethacin dissolved in the same amount of ethanol failed to alter arterial pressure, PRA, renal hemodynamic function, and renal electrolyte and water excretion in normal conscious sodium-repleted dogs.
All blood pressure and heart rate measurements were made with a Statham P23Db pressure transducer and recorded on a Hewlett-Packard 7702 B recorder. Plasma and urine electrolytes, creatinine (Cr), and />-aminohippurate (PAH) were determined by standard analytical procedures. The serum propranolol concentrations were assayed by Ayerst Laboratories. Experiment I. Acute Response to Indomethacin in Conscious Dogs with Thoracic Caval Constriction (n = 8) Measurements were made of PRA, (Co), (CPAH), arterial pressure, heart rate, urinary excretion of sodium, potassium, and water and of plasma sodium and potassium concentrations. After two 45 minute control periods, an intravenous 5 mg/Kg bolus injection of indomethacin was given and studies were made during two 45-minute periods. The same dose of indomethacin was given again and observations were made for four additional 45-minute periods.
Experiment II. Chronic Effects of Renal Denervation and Propranolol Administration
Sodium balance studies were made for 3-4 days before and for 4-6 days during propranolol administration in dogs with thoracic caval constriction and bilateral renal denervation. Blood was obtained for measurement of PRA almost daily before the 8:00 a.m. dose of propranolol. Inferior vena caval pressure was measured frequently during this study; a reference level of 6 cm from the surface of the table was used.
Co and CPAH were measured in the postabsorptive state before renal denervation and several days later after renal denervation during propranolol administration. Concurrent determinations of renal sodium excretion, mean arterial pressure, and heart rate were made. The experimental design and functions evaluated were the same as in experiment I. Propranolol was given orally for 4-6 days at 25 mg/kg per day before the acute experiment was performed. The kidneys were denervated and the dogs allowed to recover from surgery for at least 5 days. After 4 days of control measurements, propranolol administration (25 mg/kg per day) was begun. After 3 days of propranolol, the dogs were again anesthetized and the thoracic inferior vena cava was constricted sufficiently to elevate inferior vena caval pressure and to produce sodium retention (less than 3 mEq Na excreted/day). Five days after caval constriction, propranolol administration was discontinued and the dogs were observed over a 4-day recovery period. Daily measurements were made of PRA, arterial pressure, heart rate, inferior vena caval pressure, plasma sodium and potassium concentrations, and urinary sodium and potassium excretion.
Data are expressed as means ± SEM. Statistical significance of paired data was determined with the Student's <-test (Table 3 ). Analysis of variance was used to test the significance of differences between group means for all other experiments.
Results

Experiment I. Acute Effects of Indomethacin
The response to indomethacin was studied in eight conscious dogs with thoracic caval constriction and ascites (Table 1) . After two control periods, the initial 5 mg/kg bolus injection of indomethacin decreased PRA from an average control value of 15.0 to 10.5 ng angiotensin I/ml per hr (Al/ml per hr), a 30% decline (P < 0.05). The supplemental dose of indomethacin decreased PRA further to 8.5 ng Al/ml per hr, a 43% fall (P < 0.01). As the effects of indomethacin declined, PRA increased to 12.7 ng Al/ml per hr. A striking fall in renal hemodynamic function occurred. Co decreased from an average value of 72.9 to 25.9 ml/min (64%) (P < 0.01) while CPAH fell from 151 to 70 ml/min (54%) (P < 0.01) at the peaks of the responses. In two of the eight dogs, very marked falls in Co and CPAH occurred. C Cr fell from an average control value of 98 to 1 ml/min in one dog and from 56 to 2 ml/min in the other animal; as the effects of indomethacin declined, Co returned to 54 and 7 ml/min, respectively, for the two animals. Similarly, C PA H fell from an average control value in one dog of 182 to 3 ml/min and from 98 to 6 ml/min in the other dog; during recovery from indomethacin, CPAH returned to 227 ml/ min in the first dog and to 41 ml/min in the second 
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Cc, ™ creatinine clearance, CPAH ™ PAH clearance, FF •• Filtration fraction Uv ™ urine volume, E,N« -excreted sodium E* « excreted potassium, MAP • mean arterial pressure, HR -heart rats, PRA = plasma rerun activity, P N . -plasma sodium concentration, PK ~ plasma potassium concentration, RVR • renal vascular resistance * P < 0.05 from C, + C t P < 0.01 from Ci + C. animal. For the group of eight dogs, urine flow and renal potassium excretion fell strikingly while renal sodium excretion, which was very low during the control periods, decreased slightly and significantly during two of the six experimental periods (Table  1) . Mean arterial pressure, heart rate, and plasma sodium and potassium concentrations were unchanged, but renal vascular resistance rose markedly to reach a 9.6-fold increase at the peak of the response (Table 1) .
To evaluate the degree of prostaglandin synthetase inhibition, the urinary excretion of PGE 2 was measured in two additional dogs. The experimental design was the same as for the intial study with eight dogs. The two 5 mg/kg bolus injections produced an average reduction of 85% in PGE2 excretion (Table 2) ; this response occurred in association with reductions in CPAH and PRA.
Experiment II. Chronic Effects of Renal Denervation and Propranolol Administration
Measurements were made almost daily in seven dogs with renal denervation and thoracic caval constriction for 3-4 days before and during 4-6 days of propranolol administration (Table 3) ; the values presented in the table are the averages for several days. PRA decreased from 19.1 and 7.2 ng Al/ml per hr to 0.6 and 0.8 ng Al/ml per hr, respectively, in two of the seven dogs (dogs 1 and 2, Table 3) ; these values were similar to the average normal value of 0.70 ±0.17 ng Al/ml per hr for dogs studied under similar conditions in our laboratory (DeForrest et al., 1980) . In the remaining five animals, PRA decreased significantly in four of the five dogs but not to normal. Renal sodium excretion increased significantly in the two dogs in which PRA returned to normal, but was unchanged (P > 0.05) in the other five animals. Inferior vena caval pressure was unchanged during the propranolol administration in five of the six dogs studied; in the remaining dog, a slight decline occurred.
Measurements of renal hemodynamic function were made in the postabsorptive state before and during propranolol administration in dogs with caval constriction and renal denervation. The associated changes in renal sodium excretion, arterial pressure, and heart rate are recorded in Table 4 . The values presented for kidney function represent the averages for two or three renal clearance periods. Creatinine clearance and CPAH were not consistently changed by adrenergic blockade. Renal sodium excretion increased in four of the seven animals, but the average increase for the group from 1.5 to 13.9 was not significant (P > 0.05). The most striking change was the decrease in heart rate from 131 to 98 beats/min (P < 0.005). Arterial pressure was not significantly changed.
Experiment HI. Acute Response to Indomethacin in Dogs with Renal Denervation and Caval Constriction Receiving Propranolol (n = 7)
PRA appeared to decline slightly but the change was not significant (Table 5 ). The most striking change was in renal hemodynamic function; Co decreased by 51% (P < 0.01) and CPAH fell by 58% 11 ±4+ 10 ± 6: + 13 ± 6++ 11 ± 5 3 6 ± 0.9*' 3 0 ±0.9:+ 3.5 ± 0.9:+ 3.3 ± 1.7:+ ' P < 0 06 and " P < 0.01 when compared to days 5-7 whereas + P <. 0 05 and ++ P < 0.01 when compared to days 1-4.
(P < 0.01). Renal potassium excretion and urine flow decreased but sodium excretion failed to show a significant change. There were no detectable changes in plasma sodium and potassium concentrations. Arterial pressure was significantly decreased during the last three experimental periods, but heart rate was unchanged. Renal vascular resistance appeared to increase from an average control value of 0.39 to as high as 14.13 mm Hg (ml/ min)" 1 but the change was not significant because of the wide variation among animals.
Experiment IV. Chronic Effects of Thoracic Caval Constriction in Dogs with Renal Denervation Receiving Propranolol
In this study, the effects of prior renal denervation and propranolol treatment on the response to caval constriction were observed (Table 6 ). After 4 days of control measurements in dogs with renal denervation, propranolol failed to produce a change in PRA; sodium excretion appeared to increase on the first day of propranolol administration but the change was not significant. However, a significant fall in renal sodium excretion occurred on days 2 and 3 of propranolol treatment. Constriction of the thoracic inferior vena cava at the beginning of day 8 and during propranolol administration produced a striking increase in PRA, a marked reduction in renal sodium excretion, and ascites accumulation. After 5 days of caval constriction, propranolol was discontinued. The high levels of PRA, the sodium retention, and ascites formation were maintained.
Inferior vena caval pressure was unchanged when propranolol was given to dogs with renal denervation but increased from an average of 88 mm water during propranolol treatment to 185-215 mm water following caval constriction (P < 0.01). Discontinuation of propranolol did not significantly alter the high level of venous pressure. Arterial pressure was 95-99 mm Hg during the first 4 control days before propranolol and decreased slightly only on the first day after caval constriction (P < 0.01 for comparison with days 1-4). Heart rate did not change significantly until after propranolol was discontinued, at which time a significant increase occurred. Urinary potassium excretion was increased (P < 0.05) on days 1 and 4 after caval constriction, compared with the first 4 days and the 3-day propranolol control period and was increased slightly on the last day of propranolol compared with days 1 -4. Hyponatremia occurred (P < 0.05) during the first 3 days of caval constriction compared with control days 1-4, and a slight hyperkalemia resulted during the periods of propranolol {P < 0.05), propranolol plus caval constriction (P < 0.01), and during the recovery period {P < 0.05).
Discussion
In dogs with chronic thoracic caval constriction, the increased activity of the renin-angiotensin-aldosterone system and the changes in salt and water metabolism are almost identical to the findings in low cardiac output failure in humans (Davis, 1965) . Consequently, this experimental model has been used extensively to investigate the mechanisms regulating renin release in low output heart failure. It should be pointed out, however, that there is no myocardial element of failure; indeed, the pulmonary circulatory bed is underdistended and pressure is low. Thoracic caval constriction results in a decrease in cardiac output, a marked fall in renal hemodynamic function, increased filtration fraction, increased renin and aldosterone secretion, and VOL. 49, No. 2, AUGUST 1981 marked sodium retention with edema and ascites formation (Davis, 1965) .
The present study was undertaken to evaluate the relative roles of the prostaglandins and the adrenergic nervous system in the hyperreninemia of low output heart failure. A secondary objective was to determine the role of the renal prostaglandins in the maintenance of renal blood flow (RBF) and glomerular filtration rate (GFR) in heart failure.
When two 5 mg/kg bolus injections of indomethacin were given to dogs with caval constriction, PRA decreased from 15.0 to 8.5 ng angiotensin 1/ ml per hr, a 43% fall; this occurred during an 85% decrease in the urinary excretion of PGE 2 . This result confirms earlier reports of marked reductions of PGE 2 in renal venous blood (Terragno et al., 1977) and in urine (Zambraski and Dunn, 1979) in response to doses of indomethacin similar to or less than used here. It should be emphasized that the present studies were done in conscious dogs. Normal conscious dogs studied under conditions similar to those of the present study (DeForrest et al., 1980) failed to show a change in PRA in response to indomethacin. The possibility that indomethacin inhibited an adrenergically mediated component of renin release should be considered. This seems unlikely, since recent studies in conscious dogs and rats (Seymour et al., 1980) and in isolated rat glomeruli (Beierwaltes et al., 1980) provided convincing evidence that a full renin response to /5-agoniste occurred during indomethacin administration. Collectively, these findings indicate that prostaglandins contribute to the increased PRA in dogs with caval constriction. However, the relatively small decrease in PRA (43%) with this large dose of indomethacin indicates that other factors are important in the control of renin release.
Blockade of the adrenergic nervous system with bilateral renal denervation and large doses of propranolol produced a striking decrease in PRA in dogs with caval constriction. In two of seven animals, PRA returned to normal and sodium excretion increased markedly; in four of the other five dogs, PRA fell but not to normal and sodium excretion was not increased significantly. It seems likely that the primary change here was adrenergic blockade, with a resultant fall in PRA and plasma aldosterone concentrations; it is suggested that the increase in renal sodium excretion occurred in response to the return in renin and aldosterone in plasma to normal. There was no evidence that propranolol produced an indirect effect in such a way as to block the primary mechanism producing a high PRA; inferior vena caval pressure was unchanged in five of the six dogs, and the postabsorptive values for Ccr and C PA H were unaltered by propranolol. The high values for serum propranolol and the marked decrease in heart rate indicate that P adrenergic blockade was complete or nearly complete; in the five dogs of Table 3 in which PRA did not fall to normal, the average fall in heart rate was 31 beats/min. It seems likely, therefore, that the changes in PRA resulted from surgical removal of the renal nerves and phamacological blockade of the /?-adrenergic receptor which controls renin release.
The variability of the renin responses to blockade of the adrenergic nervous system in dogs with caval constriction (Table 3 ) might reflect differences in the initial level of adrenergic activity. There is no evidence for variability of adrenergic blockade, since the fall in heart rate with propranolol was consistent and marked. In view of the multifaceted control of PRA in dogs with caval constriction, the variation in nonadrenergic control mechanisms might also have contributed to the different levels of PRA achieved after adrenergic blockade.
When this group of seven dogs with adrenergic blockade (renal denervation and propranolol administration) was given indomethacin (Table 5) , the initial control level of PRA was 4.0 ng angiotensin I/ml per hr compared with 15.0 ng angiotensin I/ml per hr observed before adrenergic blockade (Table 1) , and PRA failed to decrease significantly in response to indomethacin. The present observations suggest, therefore, that the adrenergic nervous system plays a role and possibly a more important role than prostaglandins in the increased PRA in this model of experimental heart failure. These results are in striking contrast to the failure of adrenergic blockade to produce a detectable fall in PRA in sodium-depleted dogs (DeForrest et al., 1980) and to the marked decrease in PRA which occurred during prostaglandin synthesis inhibition in sodium-depleted dogs with adrenergic blockade (DeForrest et al., 1980) . In a previous report, Hanson et al. (1976) found that thoracic caval constriction produced a high PRA, sodium retention, and ascites in every animal that was receiving the large oral dose of propranolol given here. Because of this earlier finding, it was decided to study another series of animals (experiment IV and Table 6 ) in which dogs with renal denervation receiving propranolol were subjected to caval constriction. All of the six dogs studied showed a striking increase in PRA, marked sodium retention, and ascites formation in spite of adrenergic blockade. It appears, therefore, that other mechanisms are yet available to increase PRA and produce the syndrome of salt and water metabolism following caval constriction after sympathetic nervous mechanisms have been blocked. It is suggested that the fundamental mechanism available to increase renin release after blockade of the renal prostaglandins and the adrenergic nervous system is the renal vascular receptor in the renal afferent arteriole. The initial suggestion of Data et al. (1978) that prostaglandins mediate the renin release produced by the renal vascular receptor mechanism has not been confirmed. In two recent studies by Blacksheax et al. (1979) and Seymour and Zehr (1979) , both groups reported that indomethacin administration failed to attenuate the renin response to aortic constriction when arterial pressure fell below the autoregulatory range; all three studies were done in anesthetized dogs. In recent experiments in conscious dogs with a denervated, nonfiltering kidney , the increases in PRA in response to aortic constriction were essentially the same before and after inhibition of prostaglandin synthesis by indomethacin, so prostaglandins do not appear to be essential for increased function of the renal vascular receptor mechanism.
The other major finding in this study is the striking decrease in renal hemodynamic function in response to indomethacin in dogs with thoracic caval constriction. In both series of studies with indomethacin (experiments I and III), marked decreases in Co and CPAH occurred. It seems likely that the changes in CPAH reflect changes in renal plasma flow and that little or no reduction in PAH extraction occurred, since the fall in Cc, and renal electrolyte excretion closely paralleled the fall in CPAH. In two dogs of series I, Co and C PA H fell almost to zero but returned toward the control level as the effects of indomethacin disappeared. In the presence of an intact adrenergic nervous system, arterial pressure was unchanged by indomethacin (series I) and renal vascular resistance increased markedly. With blockade of the adrenergic nervous system in experiment III, arterial pressure fell, probably from loss of this important compensatory mechanism. Renal vascular resistance appeared to increase, but the change was not significant. The decreases in electrolyte excretion and urine flow in response to indomethacin in both series probably are secondary to the decreases in GFR. It seems likely that the striking drops in Co and CPAH reflect an action of the angiotensins on the renal arterioles during inhibition of prostaglandin synthetase. This interpretation is consistent with the concept of an antagonistic action between prostacyclin and angiotensin at the arteriolar level (McGiff and Quilley, 1980) . It is suggested, therefore, that prostaglandins play an important role in preventing renal arteriolar constriction in this model of heart failure.
Similar marked falls in renal function after indomethacin have been reported in a patient with congestive heart failure. Walshe and Venuto (1979) found that indomethacin produced an acute reduction in GFR with volume retention and deterioration of cardiac function in a patient with partially compensated congestive heart failure; the patient required peritoneal dialysis and recovered completely. Urinary prostaglandin E excretion was elevated in this patient and in five additional patients with congestive failure.
It is interesting to compare the renin and hemodynamic responses to blockade of the adrenergic nervous system in this model of experimental low output failure with the responses in chronic sodium depletion (DeForrest et al., 1980) . During chronic sodium depletion, adrenergic blockade produced little or no decline in PRA, whereas, in dogs with caval constriction, PRA fell in six of seven animals and fell to normal in two dogs. Arterial pressure was maintained in both experimental states. These findings are consistent with the idea that increased plasma angiotensin II provides a very important compensatory mechanism to maintain arterial pressure in the presence of a low cardiac output during sodium depletion, a concept described earlier ; also, when PRA fell after indomethacin injection in sodium-depleted dogs, arterial pressure fell in a parallel manner (DeForrest et al., 1980) . In the present study, during adrenergic blockade of dogs with caval constriction, apparently other compensatory mechanisms than the adrenergic nervous system and angiotensin II were involved in the maintenance of arterial pressure.
The present experiments demonstrate that prostaglandins help sustain the elevated PRA in dogs with caval constriction and verify that the adrenergic nervous system is also an important mechanism for increasing renin release in this model of heart failure. On the basis of the present findings and of earner work (Witty et al., 1972) , it is suggested that the renal vascular receptor mechanism is responsible for the increased PRA when the prostaglandins and adrenergic nervous system are inhibited. The macula densa also appears to be involved in the intact animal with caval constriction because the filtered load of sodium is markedly decreased (Davis et al., 1965) . Finally, the results with indomethacin demonstrate an important role for the renal prostaglandins in the maintenance of renal blood flow in this model of heart failure.
